Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

155
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
155
Antimicrobial Proteins01:23

Antimicrobial Proteins

4.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
4.9K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

192
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
192
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

539
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
539
Antibiotic Selection00:57

Antibiotic Selection

55.1K
Overview
55.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyrrospirone Z and related decahydrofluorene alkaloids produced by the new coprophilous species <i>Schizothecium keniense</i> (<i>Schizotheciaceae</i>, <i>Sordariales</i>).

MycoKeys·2026
Same author

Should describing a new species be science or data release? Rethinking introductions in fungal taxonomy.

IMA fungus·2026
Same author

Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel Antibiotic.

Journal of medicinal chemistry·2026
Same author

Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis?

Infection·2026
Same author

Aggregicyclins Shed Light on Type II Polyketide Biosynthesis in <i>Myxococcota</i>.

JACS Au·2026
Same author

Total and engineered biosynthesis of cinatrins: inhibitors of phospholipase A<sub>2</sub> and squalene synthase.

Chemical science·2026

Related Experiment Video

Updated: Sep 7, 2025

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.0K

Corallopyronin A: antimicrobial discovery to preclinical development.

Anna K Krome1,2,3, Tim Becker1,2, Stefan Kehraus2,4

  • 1Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Germany. karl.wagner@uni-bonn.de.

Natural Product Reports
|June 22, 2022
PubMed
Summary

Discovering new antibiotics like corallopyronin A is vital for combating resistant infections. This natural compound shows promise against various pathogens and filarial infections, with optimized production and formulation enhancing its potential.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K
Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
09:49

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation

Published on: October 31, 2019

22.5K

Related Experiment Videos

Last Updated: Sep 7, 2025

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.0K
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K
Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
09:49

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation

Published on: October 31, 2019

22.5K

Area of Science:

  • Natural Product Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Antibiotic resistance is a growing global health threat, necessitating novel therapeutic strategies.
  • Natural products, like corallopyronin A, offer a promising source for new antibacterial agents.
  • Corallopyronin A, isolated from *Corallococcus coralloides*, targets bacterial DNA-dependent RNA polymerase.

Purpose of the Study:

  • To review the development of corallopyronin A as a potential antibiotic candidate.
  • To highlight advancements in production and formulation of this natural compound.
  • To present preclinical efficacy data, particularly against filarial infections.

Main Methods:

  • Review of literature on corallopyronin A discovery and development.
  • Analysis of production optimization and formulation strategies.
  • Evaluation of preclinical efficacy studies against various pathogens and *Wolbachia*.

Main Results:

  • Corallopyronin A demonstrates efficacy against Gram-positive and Gram-negative pathogens, including *Chlamydia trachomatis* and *Staphylococcus aureus*.
  • The compound exhibits potent *in vivo* activity against *Wolbachia*, essential endobacteria in filarial nematodes.
  • Optimized production and formulation enhance corallopyronin A's stability and bioavailability.

Conclusions:

  • Corallopyronin A is a promising preclinical candidate for treating human filarial infections due to its anti-*Wolbachia* activity and macrofilaricidal effects.
  • Sophisticated production and formulation approaches are key to developing challenging natural products like corallopyronin A.
  • Continued research into natural product-derived antibiotics is crucial for addressing the challenge of antimicrobial resistance.